Description
An antagonist of CXCR4 (IC50s = 0.02-0.13 µg/ml); selective for CXCR4 over CXCR1-3 and CXCR5-9 (IC50s = >25 µg/ml); decreases infectious virus content in the supernatant of Jurkat cells chronically infected with HIV-1(IIIB) (EC50 = ~0.02 µg/ml); mobilizes murine and human hematopoietic stem and murine long-term repopulating cells for transplantation; increases T cell trafficking in mouse blood, spleen, and central nervous system; decreases the number of 4T1 murine mammary carcinoma cells in the lung in a mouse model of lung metastasis at 1.25 mg/kg twice per day
Formal name: 1,4-bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene, octahydrochloride
Synonyms: AMD 3100|JM 3100|SID 791
Molecular weight: 794.5
CAS: 155148-31-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS